These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 3996545)

  • 1. The potency of heparin-like activity of glycosaminoglycans released by human endothelial cells in culture.
    Shimada K; Kusumoto I; Ozawa T
    Experientia; 1985 May; 41(5):671-3. PubMed ID: 3996545
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Demonstration of a direct anti-factor Xa activity in certain heparin-related glycosaminoglycans.
    Larsson A; Fransson LA; Lewis WE
    Thromb Res; 1982 Jun; 26(6):401-9. PubMed ID: 7112518
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cultured endothelial cells produce a heparinlike inhibitor of smooth muscle cell growth.
    Castellot JJ; Addonizio ML; Rosenberg R; Karnovsky MJ
    J Cell Biol; 1981 Aug; 90(2):372-9. PubMed ID: 7287812
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GAGs-potentiated inhibition of thrombin, factor Xa and plasmin in plasma and in a purified system containing antithrombin III - correlation with total charge density.
    Cofrancesco E; Vigo A; Pogliani EM
    Thromb Haemost; 1981 Dec; 46(4):749-51. PubMed ID: 6460339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of heparin and heparinlike molecules in thrombosis and atherosclerosis.
    Rosenberg RD
    Fed Proc; 1985 Feb; 44(2):404-9. PubMed ID: 3155697
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects on platelets and on the clotting system of four glycosaminoglycans extracted from hog mucosa and one extracted from aortic intima of the calf.
    Cella G; Scattolo N; Luzzatto G; Stevanato F; Vio C; Girolami A
    J Med; 1986; 17(5-6):331-46. PubMed ID: 2953835
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-factor Xa activity of heparan sulphate.
    Thomas DP; Merton RE; Barrowcliffe TW; Mulloy B; Johnson EA
    Thromb Res; 1979; 14(2-3):501-6. PubMed ID: 155896
    [No Abstract]   [Full Text] [Related]  

  • 8. Anticoagulant activity of galactosaminoglucuronoglycan: a pharmacological study.
    Matera M; Scalia S
    Drugs Exp Clin Res; 1991; 17(1):65-73. PubMed ID: 1833172
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antithrombin III, the major modulator of intravascular coagulation, is synthesized by human endothelial cells.
    Chan TK; Chan V
    Thromb Haemost; 1981 Aug; 46(2):504-6. PubMed ID: 7302889
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence for a plasma inhibitor of the heparin accelerated inhibition of factor Xa by antithrombin III.
    MacGregor IR; Lane DA; Kakkar VV
    Biochim Biophys Acta; 1979 Sep; 586(3):584-93. PubMed ID: 476156
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of coagulation releases endothelial cell mitogens.
    Gajdusek C; Carbon S; Ross R; Nawroth P; Stern D
    J Cell Biol; 1986 Aug; 103(2):419-28. PubMed ID: 3733873
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of pentosan polysulphate (SP54) and heparin. I: Mechanism of action on blood coagulation.
    Fischer AM; Barrowcliffe TW; Thomas DP
    Thromb Haemost; 1982 Apr; 47(2):104-8. PubMed ID: 6179182
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Formation of the fibrin clot: the balance of procoagulant and inhibitory factors.
    Lämmle B; Griffin JH
    Clin Haematol; 1985 Jun; 14(2):281-342. PubMed ID: 2994929
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma anticoagulant mechanisms of heparin, heparan sulfate, and dermatan sulfate.
    Ofosu FA; Buchanan MR; Anvari N; Smith LM; Blajchman MA
    Ann N Y Acad Sci; 1989; 556():123-31. PubMed ID: 2525356
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular weight of heparin versus biologic activity. Some additional considerations.
    Losito R; Losito C
    Semin Thromb Hemost; 1985 Jan; 11(1):29-33. PubMed ID: 2579437
    [No Abstract]   [Full Text] [Related]  

  • 16. Protection of factor Xa from neutralization by the heparin-antithrombin complex.
    Teitel JM; Rosenberg RD
    J Clin Invest; 1983 May; 71(5):1383-91. PubMed ID: 6222069
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of low-molecular heparin on blood coagulation].
    Harenberg J; de Vries JX; Weber E; Zimmermann R
    Dtsch Med Wochenschr; 1984 Jun; 109(24):951-4. PubMed ID: 6734448
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of thrombin-catalyzed reactions in blood coagulation and platelet activation by heparin fractions in the absence of antithrombin III.
    Baruch D; Lindhout T; Wagenvoord R; Hemker HC
    Haemostasis; 1986; 16(2):71-81. PubMed ID: 3086193
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The anticoagulant role of heparin-like molecules in the endothelial cell surface in hemostasis--endothelial heparin-like molecules.
    Shimada K; Ozawa T
    Nihon Ketsueki Gakkai Zasshi; 1986 Dec; 49(8):1604-9. PubMed ID: 3551438
    [No Abstract]   [Full Text] [Related]  

  • 20. Inhibition of factor X and factor V activation by dermatan sulfate and a pentasaccharide with high affinity for antithrombin III in human plasma.
    Ofosu FA; Choay J; Anvari N; Smith LM; Blajchman MA
    Eur J Biochem; 1990 Oct; 193(2):485-93. PubMed ID: 2226466
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.